229 / 400
MONDAY
TUESDAY
WEDNESDAY
THURSDAY
German language Session
Q&A Modul
SCIENTIFIC PROGRAMME
221
S-360
Symposium
08:15–09:45
|
Room R13
TOPIC 4:
Affective disorders
Neuroprogression in psychiatric disorders:
detection, management and prevention
›
WPA Section: Immunology & Psychiatry
Chairs:
Angelos Halaris, USA
Brian Leonard, Ireland
001
Inflammation and kynurenine metabolites as
a cause of neuroprogression in depression
Brian Leonard, Ireland
002
From neuroprogression to neuroprotection:
the first episode as a treatment window
Michael Berk, Australia
Rose Daglas, Sue Cotton, Murat Yucel, Christos Pantelis,
Craig MacNeil, Lisa Henry, Orwa Dandash, Melissa
Hasty, Benny Liberg, Melanie Evans, Brendan Murphy,
Chao Suo, Patrick McGorry
003
Pharmacologic and non-pharmacologic inter-
ventions to arrest neuroprogression
Angelos Halaris, USA
Fotini Boufidou
004
Modelling neuronal maturation and neuropro-
gression in vitro
Flavio Kapczinski, Canada
Bianca Pfaffenseller, Bianca Wollenhaupt-Aguiar, Marco
Antônio De Bastiani, Mauro A. A. Castro, Fábio Klamt
S-361
Symposium
08:15–09:45
|
Room R12
TOPIC 7:
Personality disorders
Neuropsychiatry, cognitive neuroscience and neu-
rocrimes applied to violent, criminal and corrupt
behavior
Chairs:
Guillermo Nicolas Jemar, Argentina
Ramiro Santiago Isla, Argentina
001
Neurobiology of violent, criminal and corrupt
behavior
Guillermo Nicolas Jemar, Argentina
002
Medical implications – legal and analytical
assessment neurocrimen
Ramiro Santiago Isla, Argentina
003
Social impact and proposals transdisciplinary
approach
Ezequiel Mercurio, Argentina
S-095 (d)
Symposium (German)
08:15–09:45
|
Hall A1
TOPIC 24:
Forensic psychiatry and assessment
Schizophrenie und Delinquenz
›
DGPPN Section: Forensische Psychiatrie
Chairs:
Manuela Dudeck, Germany
Nenad Vasic, Germany
001
Aggressives Verhalten schizophrener Patienten
im Vergleich zu depressiven und substanzabhängigen
Patienten in der Allgemeinpsychiatrie
Manuela Dudeck, Germany
002
Psychopharmakologische Behandlung von
Patienten mit Schizophrenie: Allgemeinpsychiatrie
versus Maßregelvollzug
Nenad Vasic, Germany
003
Amok-Delikte als Prodromalsymptomatik von
Schizophrenien
Nahlah Saimeh, Germany
S-096 (d)
Symposium (German)
08:15–09:45
|
Hall London 1
TOPIC 18:
Pharmacotherapy
Psychopharmakotherapie bei speziellen Patien-
tengruppen
Chairs:
Niels Bergemann, Germany
Thomas Messer, Germany
001
Pharmakotherapie psychiatrischer Störungen
bei onkologischen Erkrankungen
Thomas Messer, Germany
002
Pharmakotherapie des Zwangs bei Patienten
mit schizophrenen Psychosen
Mathias Zink, Germany
003
Pharmakologische Behandlungsoptionen
der prämenstruellen dysphorischen Störung
– ein Update
Niels Bergemann, Germany
004
Pharmakologische Ursachen und Behandlungs-
möglichkeiten sexueller Funktionsstörungen
Matthias J. Müller, Germany